Target type: biologicalprocess
The chemical reactions and pathways involving lauric acid, a fatty acid with the formula CH3(CH2)10COOH. Derived from vegetable sources. [GOC:jid, PMID:15555597]
Lauric acid metabolic process is a complex biochemical pathway involved in the breakdown and utilization of lauric acid, a saturated fatty acid with 12 carbon atoms. This process is essential for energy production, cell signaling, and various physiological functions.
**1. Activation and Transport:**
* Lauric acid is initially activated by attaching a coenzyme A molecule (CoA) to form lauroyl-CoA. This reaction requires ATP and is catalyzed by an enzyme called acyl-CoA synthetase.
* Lauroyl-CoA is then transported into the mitochondria, the powerhouse of the cell, where the major steps of beta-oxidation take place.
**2. Beta-Oxidation:**
* Beta-oxidation is a cyclical process that involves four main steps:
* Dehydrogenation: Lauroyl-CoA is oxidized by acyl-CoA dehydrogenase, removing two hydrogen atoms and forming trans-2-enoyl-CoA.
* Hydration: Enoyl-CoA hydratase adds a water molecule across the double bond, forming L-3-hydroxyacyl-CoA.
* Oxidation: 3-hydroxyacyl-CoA dehydrogenase oxidizes the hydroxyl group, yielding 3-ketoacyl-CoA.
* Thiolysis: 3-ketoacyl-CoA is cleaved by a thiolase enzyme, releasing acetyl-CoA (a two-carbon unit) and a shorter acyl-CoA molecule (10 carbons in this case).
* The shortened acyl-CoA molecule then enters another round of beta-oxidation, repeating the four steps until the entire lauric acid molecule is broken down into acetyl-CoA units.
**3. Acetyl-CoA Utilization:**
* Acetyl-CoA is a crucial molecule in metabolism. It can be utilized in various pathways, including:
* **Citric acid cycle (Krebs cycle):** Acetyl-CoA enters the citric acid cycle, where it is further oxidized to generate ATP (energy currency of the cell), NADH, and FADH2.
* **Fatty acid biosynthesis:** Acetyl-CoA can be used to synthesize new fatty acids.
* **Ketone body production:** Under certain conditions, acetyl-CoA can be converted into ketone bodies, which can serve as alternative energy sources.
**4. Regulation:**
* Lauric acid metabolism is tightly regulated by various factors, including:
* **Hormonal control:** Hormones like insulin and glucagon regulate the activity of enzymes involved in lauric acid metabolism.
* **Nutritional status:** The availability of carbohydrates, proteins, and fats influences the rate of lauric acid metabolism.
* **Cellular energy demands:** The energy needs of the cell determine the rate at which lauric acid is broken down for ATP production.
**Overall, lauric acid metabolic process plays a critical role in energy generation, lipid homeostasis, and cell function. It involves a series of complex enzymatic reactions that ultimately break down lauric acid into acetyl-CoA units, which can be used in various metabolic pathways.'
"
Protein | Definition | Taxonomy |
---|---|---|
Cytochrome P450 4A11 | A cytochrome P450 4A11 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q02928] | Homo sapiens (human) |
Cytochrome P450 4A22 | A cytochrome P450 4A22 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q5TCH4] | Homo sapiens (human) |
Cytochrome P450 4Z1 | A cytochrome P450 4Z1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q86W10] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
1-aminobenzotriazole | |||
tranylcypromine | (1R,2S)-tranylcypromine : A 2-phenylcyclopropan-1-amine that is the (1R,2S)-enantiomer of tranylcypromine. tranylcypromine : A racemate comprising equal amounts of (1R,2S)- and (1S,2R)-2-phenylcyclopropan-1-amine. An irreversible monoamine oxidase inhibitor that is used as an antidepressant (INN tranylcypromine). Tranylcypromine: A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders. (From AMA Drug Evaluations Annual, 1994, p311) | 2-phenylcyclopropan-1-amine | |
proadifen hydrochloride | |||
pirlindole | pirlindole: RN given refers to parent cpd; synonym pyrazidol refers to mono-HCl; structure in Negwer, 5th ed, #2812 | carbazoles | |
1-benzylimidazole | 1-benzylimidazole: inhibits human thromboxane synthetase | ||
17-dihydroexemestane | |||
kaf156 | ganaplacide: antimalarial |